Who Supplies Rosuvastatin? Top Manufacturers & Their Global Buyers
India accounts for a significant share of global Rosuvastatin exports, with 427+ registered manufacturers shipping to buyers across 143+ countries — yet a handful of companies dominate the shipments. STRIDES PHARMA SCIENCE LIMITED holds the largest share at 15.1% (export value: $70.1M). Close behind, BIOCON PHARMA LIMITED (7.8%, $36.1M). MSN LABORATORIES PRIVATE LIMITED (7.0%, $32.6M). The Sankey diagram below maps every supplier's customer flow in detail. All figures are drawn from Indian Customs (DGFT) shipping bill records.
🏭 Market Analysis: Top Suppliers & Customer Networks
Comprehensive supplier network intelligence dashboard
Who Supplies Rosuvastatin? Top Manufacturers & Their Buyers
Flow of Rosuvastatin from leading Indian exporters to their key global customers
Supplier-Customer Network Analysis
Top Suppliers → Customer Networks
Rosuvastatin Supplier Network — Key Market Intelligence
The Rosuvastatin export market from India is led by STRIDES PHARMA SCIENCE LIMITED, which alone commands a 15.1% share, shipping $70.1M worth of product across 420 shipments. The second-largest exporter, BIOCON PHARMA LIMITED, contributes $36.1M (7.8%) to the overall market. Combined, the top two suppliers alone account for 22.9% of all Rosuvastatin exports, indicating a relatively concentrated supply base.
Across all 427 tracked manufacturers, the total Rosuvastatin export value stands at $463.3M from 13.5K shipments. The market average shipment value is $34.4K. The single largest buyer relationship in terms of trade value is ARROW PHARMACEUTICALS PTY LTD,, receiving $44.2M worth of product.
The combined buyer network spans 19 named purchasing companies, including ARROW PHARMACEUTICALS PTY LTD,, APOTEX PTY LTD,, APOTEX PTY LIMITED, BIOCON PHARMA INC, DKSH SINGAPORE PTE L and 14 others. These buyers represent pharmaceutical manufacturers, distributors, hospital procurement groups, and generic drug producers operating across multiple continents.
Market Analysis: Top Suppliers & Their Customer Networks
1STRIDES PHARMA SCIENCE LIMITED
STRIDES PHARMA SCIENCE LIMITED is the first-largest Rosuvastatin exporter from India, with a market share of 15.1% and a total export value of $70.1M across 420 shipments. Their average shipment value of $166.8K is above the market average of $34.4K, suggesting premium or bulk contract pricing.
STRIDES PHARMA SCIENCE LIMITED serves 5 named buyers in our database. ARROW PHARMACEUTICALS PTY LTD, is the dominant customer, accounting for 63.1% of this supplier's tracked business. Top customers include:
• ARROW PHARMACEUTICALS PTY LTD, — $44.2M across 265 shipments (63.1% of this supplier's total exports)
• APOTEX PTY LTD, — $15.6M across 94 shipments (22.3% of this supplier's total exports)
• ARROW PHARMACEUTICALS PTY LTD, — $4.1M across 25 shipments (5.9% of this supplier's total exports)
• APOTEX PTY LIMITED — $3.6M across 21 shipments (5.1% of this supplier's total exports)
• ARROW PHARMACEUTICALS PTY LTD, — $2.6M across 16 shipments (3.7% of this supplier's total exports)
Key Insight: STRIDES PHARMA SCIENCE LIMITED's per-shipment value of $166.8K is 385% above the market average of $34.4K, consistent with large-order contracts or value-added formulations.
2BIOCON PHARMA LIMITED
BIOCON PHARMA LIMITED is the second-largest Rosuvastatin exporter from India, with a market share of 7.8% and a total export value of $36.1M across 652 shipments. Their average shipment value of $55.3K is above the market average of $34.4K, suggesting premium or bulk contract pricing.
BIOCON PHARMA LIMITED serves 5 named buyers in our database. BIOCON PHARMA INC is the dominant customer, accounting for 86.5% of this supplier's tracked business. Top customers include:
• BIOCON PHARMA INC — $31.2M across 564 shipments (86.5% of this supplier's total exports)
• BIOCON PHARMA INC — $4.0M across 73 shipments (11.2% of this supplier's total exports)
• DKSH SINGAPORE PTE L — $425.3K across 8 shipments (1.2% of this supplier's total exports)
• EXPRESS TRAILERS LIM — $311.8K across 6 shipments (0.9% of this supplier's total exports)
• SK PHARMA LOGISTICS — $103.8K across 2 shipments (0.3% of this supplier's total exports)
Key Insight: BIOCON PHARMA LIMITED's per-shipment value of $55.3K is 61% above the market average of $34.4K, consistent with large-order contracts or value-added formulations.
3MSN LABORATORIES PRIVATE LIMITED
MSN LABORATORIES PRIVATE LIMITED is the third-largest Rosuvastatin exporter from India, with a market share of 7.0% and a total export value of $32.6M across 1.6K shipments. Their average shipment value of $20.0K is below the market average of $34.4K, reflecting a high-volume, competitive pricing strategy.
MSN LABORATORIES PRIVATE LIMITED serves 5 named buyers in our database. TO THE ORDER OF is the dominant customer, accounting for 63.6% of this supplier's tracked business. Top customers include:
• TO THE ORDER OF — $20.8M across 1.0K shipments (63.6% of this supplier's total exports)
• NOVADOZ PHARMACEUTICALS LLC — $7.5M across 377 shipments (23.1% of this supplier's total exports)
• PRIORITY HEALTHCARE — $1.8M across 91 shipments (5.6% of this supplier's total exports)
• PRIORITY HEALTHCARE — $1.4M across 70 shipments (4.3% of this supplier's total exports)
• TO THE ORDER — $1.1M across 56 shipments (3.4% of this supplier's total exports)
Key Insight: MSN LABORATORIES PRIVATE LIMITED operates with high shipment frequency (1.6K shipments) at a per-shipment value of $20.0K, indicating a broad distribution network with many smaller, regular orders.
4SUN PHARMACEUTICAL INDUSTRIES LIMITED
SUN PHARMACEUTICAL INDUSTRIES LIMITED is the fourth-largest Rosuvastatin exporter from India, with a market share of 5.5% and a total export value of $25.7M across 619 shipments. Their average shipment value of $41.5K is above the market average of $34.4K, suggesting premium or bulk contract pricing.
SUN PHARMACEUTICAL INDUSTRIES LIMITED serves 5 named buyers in our database. SUN PHARMA CANADA INC. is the dominant customer, accounting for 56.0% of this supplier's tracked business. Top customers include:
• SUN PHARMA CANADA INC. — $14.4M across 347 shipments (56.0% of this supplier's total exports)
• YUSEN LOGISTICS BENELUX BELGIUM — $9.2M across 222 shipments (35.9% of this supplier's total exports)
• MYIT MAHAR TRADING C — $864.3K across 21 shipments (3.4% of this supplier's total exports)
• NOTIFY EMERCHEME NB — $629.6K across 15 shipments (2.4% of this supplier's total exports)
• MYIT MAHAR TRADING C — $583.1K across 14 shipments (2.3% of this supplier's total exports)
Key Insight: SUN PHARMACEUTICAL INDUSTRIES LIMITED's per-shipment value of $41.5K is 21% above the market average of $34.4K, consistent with large-order contracts or value-added formulations.
5GLENMARK PHARMACEUTICALS LIMITED
GLENMARK PHARMACEUTICALS LIMITED is the fifth-largest Rosuvastatin exporter from India, with a market share of 4.5% and a total export value of $21.1M across 951 shipments. Their average shipment value of $22.1K is below the market average of $34.4K, reflecting a high-volume, competitive pricing strategy.
GLENMARK PHARMACEUTICALS LIMITED serves 5 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:
• GLENMARK PHARMACEUTICALS INC USA — $7.6M across 343 shipments (36.1% of this supplier's total exports)
• GLENMARK PHARMACEUTICALS INC USA — $6.4M across 289 shipments (30.4% of this supplier's total exports)
• NORTHSTAR DISTRIBUTION CENTER 8912 — $2.6M across 117 shipments (12.3% of this supplier's total exports)
• GLENMARK PHARMACEUTICALS INC USA — $2.3M across 103 shipments (10.8% of this supplier's total exports)
• GLENMARK PHARMACEUTICALS INC USA — $2.2M across 99 shipments (10.5% of this supplier's total exports)
Key Insight: GLENMARK PHARMACEUTICALS LIMITED operates with high shipment frequency (951 shipments) at a per-shipment value of $22.1K, indicating a broad distribution network with many smaller, regular orders.
6AUROBINDO PHARMA LTD
AUROBINDO PHARMA LTD is the fifth-largest Rosuvastatin exporter from India, with a market share of 2.6% and a total export value of $12.2M across 697 shipments. Their average shipment value of $17.5K is below the market average of $34.4K, reflecting a high-volume, competitive pricing strategy.
AUROBINDO PHARMA LTD serves 5 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:
• AUROLOGISTICS LLC (AUROBINDO PHARMA — $4.9M across 282 shipments (40.4% of this supplier's total exports)
• AUROLOGISTICS LLC, (AUROBINDO PHARM — $2.9M across 169 shipments (24.2% of this supplier's total exports)
• AUROLOGISTICS LLC — $2.1M across 120 shipments (17.2% of this supplier's total exports)
• APL SWIFT SERVICES ( — $1.2M across 66 shipments (9.5% of this supplier's total exports)
• AUROLOGISTICS LLC (AUROBINDO PHARMA — $1.1M across 61 shipments (8.7% of this supplier's total exports)
Key Insight: AUROBINDO PHARMA LTD operates with high shipment frequency (697 shipments) at a per-shipment value of $17.5K, indicating a broad distribution network with many smaller, regular orders.
From Indian Factories to Global Pharmacies — How Rosuvastatin Flows
Once Rosuvastatin leaves the manufacturing plants of companies like STRIDES PHARMA SCIENCE LIMITED and BIOCON PHARMA LIMITED, it travels to 5 destination markets with a combined import value of $463.3M. United States absorbs the largest share at 42.3% ($196.1M), followed by Australia (17.2%) and Canada (6.4%).
In United States — the top destination — named importers include BIOCON PHARMA INC, GLENMARK PHARMACEUTICALS INC., USA, GLENMARK PHARMACEUTICALS INC USA. In Australia, key buyers are ARROW PHARMACEUTICALS PTY LTD, APOTEX PTY LTD,, ARROW PHARMACEUTICALS PTY LTD,.
This geographic spread reflects Rosuvastatin's role as an essential active pharmaceutical ingredient (API) and finished dosage form — sourced primarily from India due to its cost-competitive, WHO-compliant manufacturing base. The Sankey diagram below maps these destination countries to their named importers in detail.
🌍 Market Analysis: Top Importing Countries & Importers
Comprehensive geographic market intelligence dashboard
Where Does Rosuvastatin Go? Top Importing Countries & Their Buyers
Trade flow of Rosuvastatin exports from India — top destination countries and the named companies importing it
Geographic Market Flow Analysis
Top Countries → Global Importers
Market Analysis: Top Importing Countries & Their Importers
1United States
United States ranks as the first-largest destination for Rosuvastatin imports from India, with a total trade value of $196.1M across 1,895 shipments — representing a 42.3% share of all Rosuvastatin exports. The average shipment value of $103.5K is above the global average of $34.4K, indicating high-value procurement contracts or branded formulations. This market is served by 10 tracked buyers.
Named Rosuvastatin importers in United States: BIOCON PHARMA INC is the largest buyer, accounting for 20.8% ($40.7M) of this market's total imports.
• BIOCON PHARMA INC — $40.7M (20.8% of United States's total)
• GLENMARK PHARMACEUTICALS INC., USA — $18.6M (9.5% of United States's total)
• GLENMARK PHARMACEUTICALS INC USA — $13.9M (7.1% of United States's total)
Key Insight: United States's per-shipment average of $103.5K (201% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
United States is a key market for Rosuvastatin imports from India.
2Australia
Australia ranks as the second-largest destination for Rosuvastatin imports from India, with a total trade value of $79.8M across 264 shipments — representing a 17.2% share of all Rosuvastatin exports. The average shipment value of $302.4K is above the global average of $34.4K, indicating high-value procurement contracts or branded formulations. This market is served by 3 tracked buyers.
Named Rosuvastatin importers in Australia: ARROW PHARMACEUTICALS PTY LTD is the largest buyer, accounting for 57.3% ($45.8M) of this market's total imports.
• ARROW PHARMACEUTICALS PTY LTD — $45.8M (57.3% of Australia's total)
• APOTEX PTY LTD, — $17.7M (22.1% of Australia's total)
• ARROW PHARMACEUTICALS PTY LTD, — $4.6M (5.7% of Australia's total)
Key Insight: Australia's per-shipment average of $302.4K (780% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
Australia is a key market for Rosuvastatin imports from India.
3Canada
Canada ranks as the third-largest destination for Rosuvastatin imports from India, with a total trade value of $29.9M across 2 shipments — representing a 6.4% share of all Rosuvastatin exports. The average shipment value of $14.9M is above the global average of $34.4K, indicating high-value procurement contracts or branded formulations. This market is served by 1 tracked buyer.
Named Rosuvastatin importers in Canada: SUN PHARMA CANADA INC. is the largest buyer, accounting for 48.2% ($14.4M) of this market's total imports.
• SUN PHARMA CANADA INC. — $14.4M (48.2% of Canada's total)
Key Insight: Canada's per-shipment average of $14.9M (43337% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
Canada is a key market for Rosuvastatin imports from India.
4Netherlands
Netherlands ranks as the fourth-largest destination for Rosuvastatin imports from India, with a total trade value of $21.9M across 621 shipments — representing a 4.7% share of all Rosuvastatin exports. The average shipment value of $35.2K is above the global average of $34.4K, indicating high-value procurement contracts or branded formulations. This market is served by 1 tracked buyer.
Named Rosuvastatin importers in Netherlands: BGP PRODUCTS GMBH is the largest buyer, accounting for 80.6% ($17.6M) of this market's total imports.
• BGP PRODUCTS GMBH — $17.6M (80.6% of Netherlands's total)
Key Insight: Netherlands's per-shipment average of $35.2K (3% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
Netherlands is a key market for Rosuvastatin imports from India.
5Philippines
Philippines ranks as the fifth-largest destination for Rosuvastatin imports from India, with a total trade value of $17.6M across 81 shipments — representing a 3.8% share of all Rosuvastatin exports. The average shipment value of $217.2K is above the global average of $34.4K, indicating high-value procurement contracts or branded formulations. This market is served by 1 tracked buyer.
Named Rosuvastatin importers in Philippines: SRS LIFE SCIENCES INC is the largest buyer, accounting for 32.7% ($5.7M) of this market's total imports.
• SRS LIFE SCIENCES INC — $5.7M (32.7% of Philippines's total)
Key Insight: Philippines's per-shipment average of $217.2K (532% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
Philippines is a key market for Rosuvastatin imports from India.
People Also Ask — Rosuvastatin Supplier & Trade Network
Who are the top suppliers of Rosuvastatin from India?+
Which companies buy Rosuvastatin from Indian manufacturers?+
Where does Rosuvastatin exported from India go?+
What is the market share of the top Rosuvastatin supplier from India?+
What is the average shipment value for Rosuvastatin exports from India?+
Is Rosuvastatin manufactured in India and exported globally?+
Which country imports the most Rosuvastatin from India?+
Who are the buyers of Rosuvastatin in Australia?+
How concentrated is the Rosuvastatin supplier market in India?+
How do I find verified buyers for Rosuvastatin in specific countries?+
Rosuvastatin Trade Network — Key Takeaways
- 1STRIDES PHARMA SCIENCE LIMITED is India's dominant Rosuvastatin exporter with a 15.1% market share and $70.1M in total exports — making it the single most important sourcing entity in this market.
- 2The top 427 suppliers collectively account for 42.7% of all tracked Rosuvastatin exports, with a combined trade value of $463.3M.
- 3United States is the largest destination market, absorbing 42.3% of India's Rosuvastatin exports ($196.1M). Australia (17.2%) and Canada (6.4%) follow.
- 4With 13.5K total shipments averaging $34.4K each, the Rosuvastatin export trade from India reflects both bulk API supply and finished dosage form distribution.
- 5Verified buyers across the network include ARROW PHARMACEUTICALS PTY LTD,, APOTEX PTY LTD,, BIOCON PHARMA INC, BIOCON PHARMA INC — representing a diverse base of pharmaceutical importers, distributors, and generic drug manufacturers globally.
Network Overview
Supplier Network
Country Network
Network Insights
Top supplier: 5 customers
6 suppliers → 143 countries
Network value: $463.3M
Related Analysis
Market Intelligence
Latest developments and market context
Detailed market intelligence for Rosuvastatin — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Network Construction: Supplier-to-buyer trade relationships constructed from verified shipment pairs in Indian Customs (DGFT) records for Rosuvastatin.
- 2.Flow Mapping: 427 Indian manufacturers mapped to their international buyer networks using consignee name normalization.
- 3.Value Aggregation: Trade value per supplier-buyer link aggregated from 13,477 individual shipment records. Values are FOB in USD.
- 4.Geographic Clustering: Buyer networks clustered across 143 destination countries to identify geographic concentration patterns.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
13,477 Verified Shipments
427 manufacturers in network
Expert-Reviewed
By pharmaceutical trade specialists